RE:From Sedar Nice like I said before get the results of the next set or even at 9 months data on first set which is in 3 months and that will be enough to get warrants excercised and bring up to $10 million extra cash to get 2 PH1 trials done.
BencrosMum wrote:
Trends
The Company anticipates that its current level of cash and cash equivalents will be sufficient to execute its current planned expenditures for the next 18 to 24 months. This estimate assumes completion of Study II, but does not include pre-clinical research and validation of TLD-1433 used in GBM, NSCLC or viruses such as COVID-19 as it moves towards a Phase Ib study in which additional financing will be needed.
Just need to knock bladder out of the park